Current treatments are brutal, leaving survivors with life-changing side effects. Experts believe the new discovery will lead ...

Breeze Hunter thought she had a lingering cold. When her symptoms got worse, she was diagnosed with a rare form of cancer: ...

The immune cells (called T cells) that the team identified “could [form] a new class of immunotherapy that could be applicable to up to 70% of patients with MDS and a large percentage with AML,” said ...

Extending this discovery recently in Cell, Flynn and colleagues showed ... gene have been strongly implicated in adult AML - driving about 60 percent of cases not attributed to chromosomal ...

The labs of Ryan Flynn at Boston Children’s Hospital and Konstantinos Tzelepis at the Cambridge Stem Cell Institute have found a readily druggable target on the surface of acute myeloid leukemia (AML) ...

RELATED: Doctor Says to "Avoid These Energy Drinks Like the Plague." A component of Celsius and Red Bull could raise the risk ...

The first round of chemotherapy worked very well — she went from a 95% blast, or percentage of abnormal blood cells, to 7%. To be considered in remission, a person with acute myeloid leukemia ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the first quarter ended March 31, 2025, ...

Enfortumab vedotin is now available for patients who received prior platinum-containing chemotherapy and a PD-1/L1 inhibitor ...